Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Influencers see Meta VR Glasses as potential gamechanger for virtual reality and spatial computing, says GlobalData

Meta Platforms’ debut of its 100-gram VR Glasses ignited extensive discussions among tech influencers on X. Many influencers framed the lightweight device as the form factor spatial computing needs to compete directly with heavier headsets such as the Apple Vision Pro. Conversations centered Meta’s to offload the battery and processing unit to an external pocket […]
Read more

Augmented reality transforms fan sport experience but challenges remain, reveals GlobalData

Augment Reality (AR) is reshaping sports viewing by turning live data, tactical analysis, and highlights into interactive experiences across broadcasts, stadiums, and mobile platforms, while introducing infrastructure and engagement challenges. As leagues and broadcasters pursue younger audiences and new revenue streams, AR adoption will increasingly depend on balancing immersive experiences with usability, cost, and commercial […]
Read more

Sky Italia bets connectivity over content alone, says GlobalData

Sky Italia is building on the launch of Sky Wifi fixed broadband in 2020 and a retail mobile debut in 2024 and taking on managed mobile virtual network operator (MVNO) status to gain more control over its mobile portfolio, multi-service incentives, and end-to-end customer journey. Ultimately, the operator is looking to enhance its core content […]
Read more

APAC deal activity falls 8% YoY in first eight months of 2026 amid M&A slump, reveals GlobalData

Deal activity across the Asia-Pacific (APAC) region declined during January to August 2026 compared to the same period in 2025, in line with the global trend. Subdued deal-making sentiment, ongoing macroeconomic volatility, and selective capital deployment continued to impact deal landscape. The total number of deals (comprising mergers & acquisitions (M&A), private equity and venture […]
Read more

Australia’s accelerated coal phase-out demands swift dispatchable capacity replacement, says GlobalData

Australia operates one of the world’s fastest-decarbonizing power systems, marked by a rapid structural shift away from thermal baseload generation toward solar, wind, and storage. With the retirement of major coal-fired power stations accelerating and the federal 82% renewable electricity target for 2030 approaching, the country is deploying substantial market and policy mechanisms to safeguard […]
Read more

China robotic surgical systems market to grow at 12% CAGR through 2036, forecasts GlobalData

The growing demand for advanced surgical technologies, increasing adoption of minimally invasive procedures, and the rising elderly population are expected to drive the demand for robotic-assisted surgery in China. Technological advancements, particularly the integration of artificial intelligence (AI) into robotic surgical systems, are further enhancing the capabilities and potential applications of these technologies. Against this […]
Read more

GlobalData Healthcare to host webinar on China’s next frontier in biopharma dealmaking

China’s biopharma sector is moving from a sourcing option to a strategic priority for global pharma, with deal structures shifting from single-asset licensing to full platform acquisitions. To help healthcare and life sciences leaders navigate this shift, GlobalData Healthcare, the pharmaceutical and life sciences intelligence arm of GlobalData, a leading intelligence and productivity platform, will […]
Read more

China expands role in manufacturing new FDA-approved drugs, says GlobalData

Biopharma companies are increasingly choosing to manufacture their newer FDA-approved innovator and biosimilar products at facilities in China, signaling growing industry confidence in using the country as one of the bases for its manufacturing, according to GlobalData, a leading intelligence and productivity platform. Katia Djebbar, Pharma Analyst at GlobalData, comments: “The FDA-approved products currently being […]
Read more

Structural heart occlusion devices market in Europe to grow at 6% CAGR through 2036, forecasts GlobalData

Europe’s structural heart occlusion devices market is expected to grow steadily, driven by rising prevalence of atrial fibrillation (AF), greater stroke-risk awareness, and wider adoption of minimally invasive left atrial appendage (LAA) occlusion procedures. Increasing physician experience with transcatheter procedures and improvements in device design are also expected to expand patient eligibility. Amid these trends, […]
Read more

Global deal activity falls 4% YoY during January–August 2026, finds GlobalData

Persistent macroeconomic uncertainty, elevated financing costs, and geopolitical headwinds continued to weigh on dealmaking activity, resulting in a 4% year-on-year (YoY) decline in the total number of deals (comprising mergers & acquisitions (M&A), private equity, and venture capital (VC)) announced globally during January–August 2026 compared with the same period in 2025, according to GlobalData, a […]
Read more

Zoom continues to enhance platform and position itself well for the future, says GlobalData

Zoom continues to enhance its platform with wide-ranging improvements, expanding the ZoomMate AI assistant with new models and languages alongside a redesigned Contact Center workspace. Fulfilling the company’s vision and extending its corporate transformation, these collaboration trends position the company well for the future, keeping it poised for further development, according to GlobalData, a leading […]
Read more

South Korea’s dry eye market to see intensified competition with third homegrown drug approval, says GlobalData

South Korea’s Ministry of Food and Drug Safety has approved recoflavone (Latica/Recodu) for moderate to severe dry eye disease. Developed jointly by GL PharmaTech and Aju Pharmaceutical, recoflavone is the first domestically developed dry eye disease treatment approved in South Korea and the third prescription treatment authorized for the indication. The approval is expected to […]
Read more

CDMOs invest in European API capabilities to balance changing demand and supply chain risks, says GlobalData

Contract development and manufacturing organizations (CDMOs) are ramping up their active pharmaceutical ingredient (API) investments in Europe. A series of recent deals shows how companies are strengthening their infrastructure in the region, as they position themselves to develop and supply newer, more complex medicines, says GlobalData, a leading intelligence and productivity platform. GlobalData’s monthly Bio/Pharmaceutical […]
Read more

Porsche’s battery recycling signals next phase of EV supply chain localization in Europe, says GlobalData

Battery-material supply chains are tightening as electric vehicle (EV) volumes rise, critical-mineral prices remain volatile, and regulation pushes manufacturers toward traceability and recycled content. Porsche has now produced battery cells using cathode active material made entirely from recycled lithium, nickel, cobalt, and manganese under a high-voltage battery recycling pilot launched with partners including German recycler […]
Read more

AI climate benefits struggle to compete with rising environmental footprint, warns GlobalData

Artificial intelligence’s (AI) climate benefits risk being overstated as surging data center emissions and water consumption threaten to outpace efficiency gains. While predictive AI can deliver measurable reductions across energy, agriculture, and buildings, the environmental cost of generative AI remains substantial, with limited evidence that its climate benefits can offset its footprint, says GlobalData, a […]
Read more
1 2 3 4 5 6 … 783